← All US exec pay

Gilead Sciences, Inc. (GILD)

CEO compensation · Health Care · Biotechnology · FY2025
CEO total comp
$28.44M
Sector percentile
96.5th
Sector median
$7.11M
CEO pay ratio
119:1

Versus Health Care peers

Daniel P. O’Day's FY2025 total of $28.44M ranks at the 96.5th percentile among 174 sector CEOs · sector median $7.11M · p75 $15.12M.

CEO pay mix

CEO total comp over time

Named Executive Officers — FY2025

ExecutiveTitleSalaryBonusStockOptionIncentiveOtherTotalSource
Daniel P. O’Day CEO $1.80M—$15.24M $4.50M$4.85M$2.06M $28.44M SEC ↗
Dietmar Berger M.D., Ph.D. Chief Medical Officer $0.97M$3.00M$7.00M $1.00M$1.60M$0.35M $13.92M SEC ↗
Johanna Mercier Chief Commercial and Corporate Affairs Officer $1.18M—$4.56M $1.30M$2.15M$0.10M $9.30M SEC ↗
Andrew D. Dickinson CFO $1.12M—$4.32M $1.30M$1.96M$0.07M $8.77M SEC ↗
Deborah H. Telman General Counsel $0.98M—$3.07M $0.90M—$0.06M $5.00M SEC ↗

Every figure links to its source SEC proxy (DEF 14A). Extraction: edgartools/ECD-XBRL.